zavedos
pfizer italia s.r.l. - idarubicina - idarubicina
idarubicina accord
accord healthcare, s.l.u. - idarubicina - idarubicina
doxorubicina actavis
actavis group ptc ehf - doxorubicina - doxorubicina
doxorubicina mylan
mylan s.p.a. - doxorubicina - doxorubicina
doxorubicina aurobindo
eugia pharma (malta) limited - doxorubicina - doxorubicina
erwinase
porton biopharma ltd - asparaginasi - asparaginasi
vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - leucemia, mieloide - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.
enrylaze
jazz pharmaceuticals ireland limited - crisantaspase - linfoma di leucemia linfoblastica a cellule precursori - agenti antineoplastici - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.
fludara
sanofi b.v. - fludarabina - fludarabina
calcio levofolinato teva generics
teva b.v. - calcio levofolinato - calcio levofolinato